Eli Lilly, Novo Nordisks main competitor for diabetes and weight loss medication, still holds its patent in Canada and theres no imminent patent expiry for its drugs: Mounjaro and Zepbound
Recent studies have confirmed that the anti-inflammatory benefits of Sema require GLP-1R in the central nervous system (CNS), and Atro blocks do not affect the anti-inflammatory effects of GLP-1RA 75
Tirzepatide vials come in various concentrations, and the same formula applies: Units = (Dose in mg / Concentration in mg/mL) x 100
Geffen commented that as GLP-1 medications are being prescribed to a huge number of patients and as its been observed that not all patients are symptom free and not side effect free doctors must be very careful to make sure their patients eye health is not compromised utilizing these medications
doi:10.3389/fnut.2022.1013055 [25] Zhao JV, Yeung WF, Chan YH, et al
Losing 1-2 pounds weekly is a more realistic and maintainable goal